Trimedoxime bromide
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
1,1′-propane-1,3-diylbis{4-[(E)-(hydroxyimino)methyl]pyridinium} dibromide | |
| Clinical data | |
| Legal status |
|
| Routes of administration | Intramuscular injection |
| Pharmacokinetic data | |
| Biological half-life | 2 hours (mean) |
| Identifiers | |
| CAS Number | 56-97-3 |
| ATC code | None |
| PubChem | CID 5359236 |
| ChemSpider | 4514238 |
| UNII |
ED0GXI9825 |
| Chemical data | |
| Formula | C15H18Br2N4O2 |
| Molar mass | 446.14 g/mol |
Trimedoxime bromide (INN), also known as dipyroxime or TMB-4, is an oxime used in the treatment of organophosphate poisoning.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Wednesday, July 08, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
